PUBLIC COMPANY
saveNovadip Biosciences SA
updated 13d ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia.
- phase2Proof-of-concept Study With NVDX3 for Treatment of Distal Radius Fractures.
- phase2Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis
- phase2Long-term Safety Trial with NVDX3
- phase2Prospective Study in Adults Evaluating Safety & Efficacy of NVD003 for Bone Reconstruction to Treat Lower Limb Nonunion
- phase1NVD-003 in the Treatment of Congenital Pseudarthrosis of the Tibia
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that